Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production

Cell Host and Microbe

Volumn 16, Issue 6, 2014, Pages 722-735

  Mashiba, Michael ^a   Collins, David R ^b   Terry, Valeri H ^a   Collins, Kathleen L ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LENTIVIRUS VECTOR; RALTEGRAVIR; UBIQUITIN PROTEIN LIGASE; VIRUS ENVELOPE PROTEIN; VPR PROTEIN; CARRIER PROTEIN; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VPRBP PROTEIN, HUMAN;

ARTICLE; CELL COUNT; CELL FUSION; DEGRADATION; ENDOCYTOSIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RATE; LYSOSOME; MACROPHAGE; MACROPHAGE CULTURE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; TARGET CELL; VIRION; VIRUS MUTANT; VIRUS PARTICLE; WILD TYPE; GENETICS; HELA CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CARRIER PROTEINS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERONS; MACROPHAGES; VIRION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84920573367     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.10.014     Document Type: Article

References (47)

1. J. Ahn, T. Vu, Z. Novince, J. Guerrero-Santoro, V. Rapic-Otrin, and A.M. Gronenborn HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation J. Biol. Chem. 285 2010 37333 37341
2. D. Ayinde, C. Maudet, C. Transy, and F. Margottin-Goguet Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr? Retrovirology 7 2010 35
3. J.W. Balliet, D.L. Kolson, G. Eiger, F.M. Kim, K.A. McGann, A. Srinivasan, and R. Collman Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate Virology 200 1994 623 631
4. J.P. Belzile, G. Duisit, N. Rougeau, J. Mercier, A. Finzi, and E.A. Cohen HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase PLoS Pathog. 3 2007 e85
5. G. Berger, S. Durand, G. Fargier, X.N. Nguyen, S. Cordeil, S. Bouaziz, D. Muriaux, J.L. Darlix, and A. Cimarelli APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells PLoS Pathog. 7 2011 e1002221
6. C.C. Carter, A. Onafuwa-Nuga, L.A. McNamara, J. Riddell 4th, D. Bixby, M.R. Savona, and K.L. Collins HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs Nat. Med. 16 2010 446 451
7. R. Chen, E. Le Rouzic, J.A. Kearney, L.M. Mansky, and S. Benichou Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages J. Biol. Chem. 279 2004 28419 28425
8. K.A. Clouse, D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A.S. Fauci, and T.M. Folks Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone J. Immunol. 142 1989 431 438
9. D.R. Collins, and K.L. Collins HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion PLoS Pathog. 10 2014 e1003851
10. R. Collman, J.W. Balliet, S.A. Gregory, H. Friedman, D.L. Kolson, N. Nathanson, and A. Srinivasan An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1 J. Virol. 66 1992 7517 7521
11. R.I. Connor, B.K. Chen, S. Choe, and N.R. Landau Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes Virology 206 1995 935 944
12. J.L. DeHart, E.S. Zimmerman, O. Ardon, C.M. Monteiro-Filho, E.R. Argañaraz, and V. Planelles HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system Virol. J. 4 2007 57
13. D.A. Eckstein, M.P. Sherman, M.L. Penn, P.S. Chin, C.M. De Noronha, W.C. Greene, and M.A. Goldsmith HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells J. Exp. Med. 194 2001 1407 1419
14. T.M. Folks, K.A. Clouse, J. Justement, A. Rabson, E. Duh, J.H. Kehrl, and A.S. Fauci Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone Proc. Natl. Acad. Sci. USA 86 1989 2365 2368
15. E.O. Freed, and M.A. Martin The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection J. Biol. Chem. 270 1995 23883 23886
16. F. Hladik, P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M.J. McElrath Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1 Immunity 26 2007 257 270
17. K. Hrecka, M. Gierszewska, S. Srivastava, L. Kozaczkiewicz, S.K. Swanson, L. Florens, M.P. Washburn, and J. Skowronski Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle Proc. Natl. Acad. Sci. USA 104 2007 11778 11783
18. K. Hrecka, C. Hao, M. Gierszewska, S.K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M.P. Washburn, and J. Skowronski Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein Nature 474 2011 658 661
19. C. Jolly, K. Kashefi, M. Hollinshead, and Q.J. Sattentau HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse J. Exp. Med. 199 2004 283 293
20. R. Kaushik, X. Zhu, R. Stranska, Y. Wu, and M. Stevenson A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection Cell Host Microbe 6 2009 68 80
21. N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx Nature 474 2011 654 657
22. N. Laguette, C. Brégnard, P. Hue, J. Basbous, A. Yatim, M. Larroque, F. Kirchhoff, A. Constantinou, B. Sobhian, and M. Benkirane Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing Cell 156 2014 134 145
23. H. Lahouassa, W. Daddacha, H. Hofmann, D. Ayinde, E.C. Logue, L. Dragin, N. Bloch, C. Maudet, M. Bertrand, and T. Gramberg SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates Nat. Immunol. 13 2012 223 228
24. J. Lama, A. Mangasarian, and D. Trono Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner Curr. Biol. 9 1999 622 631
25. S.M. Lang, M. Weeger, C. Stahl-Hennig, C. Coulibaly, G. Hunsmann, J. Müller, H. Müller-Hermelink, D. Fuchs, H. Wachter, and M.M. Daniel Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus J. Virol. 67 1993 902 912
26. E. Le Rouzic, and S. Benichou The Vpr protein from HIV-1: distinct roles along the viral life cycle Retrovirology 2 2005 11
27. E. Le Rouzic, N. Belaïdouni, E. Estrabaud, M. Morel, J.C. Rain, C. Transy, and F. Margottin-Goguet HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase Cell Cycle 6 2007 182 188
28. Y.L. Lu, R.P. Bennett, J.W. Wills, R. Gorelick, and L. Ratner A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles J. Virol. 69 1995 6873 6879
29. M.H. Malim, and M. Emerman HIV-1 accessory proteins - ensuring viral survival in a hostile environment Cell Host Microbe 3 2008 388 398
30. C.M. McCall, P.L. Miliani de Marval, P.D. Chastain 2nd, S.C. Jackson, Y.J. He, Y. Kotake, J.G. Cook, and Y. Xiong Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development Mol. Cell. Biol. 28 2008 5621 5633
31. L.W. McGinnes, and T.G. Morrison Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes J. Virol. 80 2006 2894 2903
32. L.A. McNamara, A. Onafuwa-Nuga, N.T. Sebastian, J. Riddell 4th, D. Bixby, and K.L. Collins CD133+ HPCs harbor HIV genomes in a subset of optimally treated people with long-term viral suppression J. Infect. Dis. 207 2013 1807 1816
33. J.M. Norman, M. Mashiba, L.A. McNamara, A. Onafuwa-Nuga, E. Chiari-Fort, W. Shen, and K.L. Collins The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells Nat. Immunol. 12 2011 975 983
34. A. Ono, and E.O. Freed Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus J. Virol. 73 1999 4136 4144
35. M. Peeters, and V. Courgnaud Overview of primate lentiviruses and their evolution in non-human primates in Africa HIV Sequence Compendium 2002 2 23
36. T. Pertel, C. Reinhard, and J. Luban Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon Retrovirology 8 2011 49
37. S. Priet, J.M. Navarro, N. Gros, G. Quérat, and J. Sire Differential incorporation of uracil DNA glycosylase UNG2 into HIV-1, HIV-2, and SIV(MAC) viral particles Virology 307 2003 283 289
38. F. Rey, M. BouHamdan, J.M. Navarro, I. Agostini, K. Willetts, M. Bouyac, C. Tamalet, B. Spire, R. Vigne, and J. Sire A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells J. Gen. Virol. 79 1998 1083 1087
39. T.M. Ross, A.E. Oran, and B.R. Cullen Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein Curr. Biol. 9 1999 613 621
40. P. Salmon, and D. Trono Production and titration of lentiviral vectors Curr. Protoc. Hum. Genet. Chapter 12 2007 Unit 12, 10
41. R.D. Salter, D.N. Howell, and P. Cresswell Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids Immunogenetics 21 1985 235 246
42. N. Sharova, Y. Wu, X. Zhu, R. Stranska, R. Kaushik, M. Sharkey, and M. Stevenson Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction PLoS Pathog. 4 2008 e1000057
43. M. Somasundaran, M. Sharkey, B. Brichacek, K. Luzuriaga, M. Emerman, J.L. Sullivan, and M. Stevenson Evidence for a cytopathogenicity determinant in HIV-1 Vpr Proc. Natl. Acad. Sci. USA 99 2002 9503 9508
44. A.M. Spivak, S.A. Rabi, M.A. McMahon, L. Shan, A.R. Sedaghat, C.O. Wilke, and R.F. Siliciano Short communication: dynamic constraints on the second phase compartment of HIV-infected cells AIDS Res. Hum. Retroviruses 27 2011 759 761
45. T.S. Theodore, G. Englund, A. Buckler-White, C.E. Buckler, M.A. Martin, and K.W. Peden Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions AIDS Res. Hum. Retroviruses 12 1996 191 194
46. X. Wen, K.M. Duus, T.D. Friedrich, and C.M. de Noronha The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor J. Biol. Chem. 282 2007 27046 27057
47. X. Wen, L. Casey Klockow, M. Nekorchuk, H.J. Sharifi, and C.M. de Noronha The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover PLoS ONE 7 2012 e30939